Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (25)

2024

  1. Impact of the Mediterranean Diet on the Gut Microbiome of a Well-Defined Cohort of Healthy Individuals

    Nutrients, Vol. 16, Núm. 6

2023

  1. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  2. Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  3. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  4. Microbiome profile and calprotectin levels as markers of risk of recurrent Clostridioides difficile infection

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  5. Non-nosocomial Healthcare-Associated Infective Endocarditis: A Distinct Entity? Data from the GAMES Series (2008-2021)

    Open Forum Infectious Diseases, Vol. 10, Núm. 8

2022

  1. Abiotrophia spp. and Granulicatella spp. Infective Endocarditis: A Contemporary Perspective

    Frontiers in bioscience (Elite edition), Vol. 14, Núm. 3, pp. 23

  2. Air pollution and health prevention: A document of reflection

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 307-332

  3. Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 3, pp. 279-283

2020

  1. Clinical impact of a Clostridioides (Clostridium) difficile bedside infectious disease stewardship intervention

    JAC-Antimicrobial Resistance, Vol. 2, Núm. 3

2019

  1. Is it reasonable to perform fecal microbiota transplantation for recurrent clostridium difficile infection in patients with liver cirrhosis?

    Revista Espanola de Quimioterapia

2018

  1. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    Clinical Microbiology and Infection, Vol. 24, pp. e1-e38

2017

  1. Performance of a quantitative pcrbased assay and beta-D-glucan detection for diagnosis of invasive candidiasis in very-low-birth-weight preterm neonatal patients (candineo study)

    Journal of Clinical Microbiology, Vol. 55, Núm. 9, pp. 2752-2764

2015

  1. The search for endocarditis in patients with candidemia: a systematic recommendation for echocardiography? A prospective cohort

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 34, Núm. 8, pp. 1543-1549

2014

  1. Spread of streptococcus pneumoniae serotype 8-st63 multidrug-resistant recombinant clone, Spain

    Emerging Infectious Diseases, Vol. 20, Núm. 11, pp. 1848-1856

2006

  1. Combinations of PBPs and MurM protein variants in early and contemporary high-level penicillin-resistant Streptococcus pneumoniae isolates in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 5, pp. 983-986

2005

  1. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 1965-1972

2004

  1. Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae Clones, Spain

    Emerging Infectious Diseases, Vol. 10, Núm. 10, pp. 1751-1759

  2. Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjects

    Vaccine, Vol. 22, Núm. 23-24, pp. 2966-2973

2002

  1. Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]

    Journal of Antimicrobial Chemotherapy